Merck Sues To Nix Mylan’s Plans For Diabetes Generic

Merck & Co. Inc. filed a lawsuit on Thursday in West Virginia federal court seeking to block competing drug maker Mylan NV from moving ahead with plans to sell generic versions of two diabetes drugs that Merck says would infringe patents it owns.

Read this piece in its entirety at Law360.

Comments

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s